Week 8 Flashcards
Effector T cell populations
CD8+ T cells: cytotoxic T lymphocytes
CD4+ T cells: ‘helper T cells’
Th1, Th2, Th17, Tfh, TReg
Functional role in immunity and autoimmunity
Mechanism of action including cytokine profiles and effector functions
Generating an “army” of T cells
One T cell in the “army” is not enough to eliminate an infection or control cancer
First requirement is to replicate the cells that constitute the “army”
Second requirement is to “arm” the “Army”- differentiate
Naive T cells must proliferate and differentiate
T cells having matured in the thymus enter the circulation in a largely undifferentiated state- they have little effector function
- when they leave they are either CD4, CD8 or T regulatory cells
At this stage they’re known as naive T cells (not encountered pathogen)
During this time the frequency of T cells for any given peptide/MHC complex is very low
-proliferation of antigen-specific cells
-differentiation to provide effector function
To initiate proliferation and differentiation we need to present the antigen via the MHC complex located on the surface of an APC to the T cell
In this case the APC is a dendritic cell
Naive T cells activated by antigen presentation in secondary lymphoid organs like lymph nodes
Antigen presenting cells
Dendritic cells
Macrophages
B cells
There are many similarities between them: they’re efficient at taking up antigens and processing it, they then upregulate the level of MHC expression ( B cell already high) and also upregulate co-stimulation molecule activity
Differences:
-dendritic cell: found throughout the body, result in activation of naive T cells
-macrophages: found in lymphoid and connective tissue and in body cavities, result in activation of macrophages
-B cells- found in lymphoid tissue and peripheral blood, result in delivery of help to B cells
Migration of dendritic cells
Tissue dendritic cells migrate to the draining lymph nodes when activated
Langerhans cells: dendritic cells found in epidermis of skin in a resting state, they are activated by presence of pathogen of the products of inflammation due to presence of pathogen, these dendritic cells will alter molecules on their surface which allows them to migrate into draining lymph nodes, this is where they activate T cells
Molecules on dendritic cells for migration
An immature dendritic cell has a number of receptors on its surface e.g patterns recognition receptors
It also has chemokines receptors
Chemokines receptors allows the cells to migrate from one place to another via chemokines
Chemokine receptors 1,2,5,6 are inflammatory chemokines receptors, so inflammatory chemokines made in tissue allow dendritic cell to migrate to site of inflammation/infection
However once the dendritic cell has encountered a pathogen it needs to migrate into draining lymph node
To do this once the dendritic cell is activated by PAMPS due to the presence of a pathogen, it processes pathogen derived antigen, down regulates expression of inflammatory chemokine receptors and then switches on another chemokine receptor CCR7 which allows it migrate to lymphoid organs
Once the dendritic cells are in the lymph node, they need to alter the way they can interact with T cells:
-any antigen that the dendritic cell has taken up needs to be processed and attached to MHC to be presented on cell surface
-it also needs to further increase expression of MHC and costimulatory molecules B7
Naive T cell activation
Naive T cells are present in the T cell zone of secondary lymphoid organs such as lymph nodes
They migrate around and if they come into contact with a dendritic cell that presents the peptide MHC complex to which its T cell receptor has high affinity for the T cell is activated
It then proliferates to make more copies of itself then some of those T cells exit lymph node to populate periphery
Molecular interactions between dendritic cells and T cells
The T cell receptor binds to the peptide MHC complex
CD4 T cell binds to MHC class 2
T cell receptor binds to combination of peptide and MHC
This produces signal one- primary signal for activation
However for a naive T cell signal one is not enough
Additionally B7.1 and B7.2 (costimulatory molecules) will bind to CD28 on the T cell- this produces signal 2
-CD28 on T cell is a co-stimulatory molecule that induces a very strong and prolonged activation signal that aids cell survival
Signal 3- for T cell differentiation. T cell have receptors for many molecules in the environment eg cytokines, the binding of specific molecules drives differentiation cells into specific effector T cells. After the body has dealt with the invading pathogen, it begins reduce effector T cell number by apoptosis, this helps reduce swelling of lymph nodes. However some of the effector T cells are retained as memory cells to hep with the returning of same pathogen
CD8+ cytotoxic T cells
Two major killing mechanisms:
-granules contain perforin and granzymes
-Fas ligand (FasL) on T cell binds to Fas on the target cell triggering apoptosis
Kills virus infected cells
Pathogens targeted: viruses, some intracellular bacteria
CD4 Th1 cells
Activate infected macrophages, provide help to B cells for antibody production
Pathogens targeted: microbes that persist in macrophage vesicles, extracellular bacteria
Differentiation:
-differentiate in the presence of IL-12 and secrete IFN gamma when stimulated by antigen
IFN gamma acts as a positive feedback loop to further enhance differentiation to Th1 phenotype
Key functions:
-IFN gammas stimulates infected macrophages to help control infected by increasing:
-MHC expression
-costimulatory molecule expression
-nitric oxide (NO) production
-phagolysosome maturation
-TNF-alpha production
M.tuberculosis is controlled by Th1 cells activating infected macrophages
Granuloma can form with a sheath of T cells surrounding a collection of infected multi-nucleated giant cells (fused macrophages)
Deficiencies in Th1 cells results in reactivation of latent infections or inadequate control of de novo infection
CD4+ Th1 cells in pathology
Th1 cells are also found at affected sites in autoimmune and inflammatory disease:
-multiple sclerosis
-autoimmune thyroiditis
-rheumatoid arthritis
-type 1 diabetes
-psoriasis
-Crohn’s disease
-allograft rejection
CD4 Th2 cells
Functions: provide help to B cells for antibody production, especially switching to IgE
Pathogens targeted: helminth parasites, large extracellular organisms
Differentiation: to a Th2 phenotype is stimulated by Il-4
Key functions:
-Th2 cells secrete IL-4, IL-5 and IL-13
-these act on effector cells including basophils, eosinophils and mast cells, which promote resistance to large extracellular helminth parasites
-IL-4 from Th2 cells promotes B cell class switching to IgE
CD4+Th2 cells in pathology
Th2 cells implicated in allergic and asthmatic disease
IL-4: smooth muscle spasm
IL-13: mucus hypersecretion, goblet cell hyperplasia
IL-5: eosinophilic inflammation
Unwanted effects of Th2-derived cytokines on innate immune effectors in the airway
CD4Th17 cells
Enhance neutrophil response, promote barrier integrity (skin, intestine)
Pathogen targeted: fungal infection
Differentiation and function:
-differentiation to a Th17 phenotype is stimulated by IL-1b, IL-6, IL-21, TGF-B and maintained by IL-23
-Th17 express the transcription factor ROR-gammat and IL-17A/F, IL-22, CCL20
-protect against fungal infection and some bacteria
-increases neutrophil recruitment and controls epithelial barrier function
-also implicated in autoimmunity, for example multiple sclerosis, Crohn’s disease, rheumatoid arthritis
Tfh cells Follicular helper
B cell help isotype switching, antibody production
Pathogen: all types
Tfh act within the secondary lymphoid compartment to help B cells
Increases Tfh differentiation by IL-21
Express the transcription factor Bcl-6
Express the chemokine receptor CXCR5 to allow migration towards B cell areas
co-express a wide range of Th phenotypes to allow appropriate B cell help